Skip to content
naulon

Not checkedNot checked for notices yet.

Exploring the multi-target enzyme inhibition potential of new sulfonamido-thiazoline derivatives; synthesis and computational studies

Imran Shafique, Aamer Saeed, Atteeque Ahmed and 7 more

Results in Chemistry · 2022

doi:10.1016/j.rechem.2022.100656 (opens in a new tab)

We email you when a new notice or a question about this paper appears.

Abstract

A small library of ten new Nimesulide-iminothiazolines conjugates was synthesized by the reduction of nitro group of Nimesulide followed by conversion into variously substituted acyl thioureas. Heterocyclization of the latter with phenacyl bromide afforded the products (7a-j) in good to excellent yields and high purity. The newly synthezied (7a-j) were screend for inhibition of acetylcholinesterase (AChE), butyrylcholinesterase (BChE), carbonic anhydrase I (hCA I) and carbonic anhydrase II (hCA II). Most of the synthesized molecules were more effective than standard inhibitors tacrine, and acetazolamide against AchE, BchE and against CA I and CA II respectively. Compounds 7 h, 7f, 7d and 7i were the most potent compounds against hCA I&II. Whilst compounds 7a, 7d and 7f showed highest inhibition against acetylcholinesterase (AChE), butyrylcholinesterase (BChE) when compared with standard inhibitor Tacrine. In silico studies were also performed to find the type of interactions. Molecular docking was accomplished to explore the putative binding mode of interactions of selective inhibitors. Finally, the ADMET analysis of the molecules was also performed.

Abstract licence: CC BY-NC-ND

References62

    40 more references, whose wording the paper’s licence keeps private.

    All 62 references

    Reads

    Read by people on this page

    None yet.

    Checked or read by AI through naulon

    None yet.

    A person counts once a day per paper. We keep no cookie and no address: a reader is a hash that changes every day. Any month under five reads shows no number.

    Are you an author?

    Is this your paper?

    Claim it to add your note and be paid when agents cite it. Free.